immun
system
play
central
role
health
mainten
also
pathogenesi
excess
immun
associ
instanc
autoimmun
diseas
exampl
multipl
sclerosi
type
diabet
psoriasi
lupu
rheumatoid
arthriti
inflamm
sepsi
inflammatori
bowel
diseas
allergi
well
cell
organ
reject
defici
immun
hand
link
cancer
suscept
infect
investig
immunemedi
diseas
human
restrict
access
relev
tissu
sampl
brain
multipl
sclerosi
joint
rheumatoid
arthriti
constitut
major
limit
cell
immun
system
howev
becom
educ
implement
function
recircul
central
peripher
lymphoid
organ
well
migrat
site
injuri
via
blood
figur
blood
flow
throughout
bodi
carri
educ
immun
cell
one
site
anoth
act
pipelin
immun
system
inde
prefer
rout
immun
cell
reach
lymph
node
antigenspecif
immun
respons
develop
exit
node
outgo
lymphat
vessel
cell
reach
bloodstream
transport
tissu
throughout
bodi
upon
patrol
tissu
gradual
drift
back
lymphat
system
reenter
blood
begin
cycl
complex
pattern
recircul
depend
state
cell
activ
adhes
molecul
express
immun
endotheli
cell
presenc
chemotact
molecul
select
attract
particular
popul
blood
cell
circul
immun
cell
addit
expos
factor
releas
system
wide
rang
molecular
cellular
profil
assay
current
avail
studi
human
immun
system
figur
level
sophist
instrument
polychromat
flow
cytomet
one
immunologist
favorit
tool
increas
past
year
major
technolog
breakthrough
also
occur
field
genom
proteom
thu
creat
today
uniqu
opportun
studi
human
be
health
diseas
inher
heterogen
dictat
larg
collect
sampl
analyz
among
highthroughput
molecular
profil
technolog
avail
today
genom
approach
scalabl
breadth
robust
therefor
best
suit
studi
human
popul
human
genom
investig
two
differ
angl
consist
either
determin
make
measur
output
sequenc
variat
detect
use
instanc
singl
nucleotid
polymorph
snp
chip
permit
identif
common
polymorph
rare
mutat
associ
diseas
hundr
thousand
snp
type
use
platform
yield
genomewid
hypothesisfre
scan
genet
associ
given
phenotyp
interest
mani
genomewid
associ
studi
often
refer
gwa
publish
recent
year
number
investig
genet
underpin
immunerel
diseas
notabl
studi
use
pinpoint
gene
pathway
may
involv
pathogenesi
autoimmun
diseas
associ
common
genet
variant
resist
infect
also
report
howev
paramet
measur
approach
determin
hered
chang
throughout
life
individu
contrast
transcript
abund
paramet
measur
second
genomewid
profil
approach
transcript
activ
larg
depend
environment
factor
result
rna
abund
chang
dynam
time
instanc
set
transcript
may
induc
respons
infecti
challeng
return
baselin
level
follow
pathogen
clearanc
dynam
chang
cellular
make
tissu
also
effect
chang
transcript
abund
measur
genomewid
scale
transcript
profil
obtain
mani
human
tissu
includ
instanc
skin
muscl
liver
kidney
brain
statu
immun
system
best
monitor
profil
transcript
abund
blood
inde
profil
transcript
abund
blood
provid
snap
shot
complex
immun
network
oper
throughout
entir
bodi
howev
proven
valid
approach
find
clue
pathogenesi
well
identifi
potenti
biomark
number
challeng
limit
exist
data
interpret
one
firstli
volum
data
gener
studi
overwhelm
necessari
integr
inform
multitud
sourc
studi
design
qualiti
control
data
sampl
inform
importantli
clinic
inform
order
result
interpret
secondli
chang
transcript
abund
observ
complex
tissu
blood
caus
regul
gene
transcript
activ
also
rel
chang
abund
cell
popul
express
transcript
constant
level
thirdli
addit
pathogen
process
number
factor
may
affect
blood
transcript
abund
confound
analysi
medic
comorbid
two
factor
often
restrict
patient
select
complic
data
interpret
review
discuss
strategi
recent
develop
address
limit
realtim
pcr
technolog
current
consid
gold
standard
analysi
gene
express
howev
use
measur
abund
limit
number
transcript
introduc
year
ago
dna
microarray
routin
use
measur
transcript
abund
genomewid
scale
technolog
reli
dens
array
oligonucleotid
probe
captur
complementari
sequenc
present
biolog
sampl
variou
concentr
probe
deposit
solid
surfac
print
microarray
synthes
situ
affymetrix
genechip
bound
glass
bead
lodg
well
etch
surfac
glass
slide
illumina
beadarray
label
materi
captur
microarray
imag
rel
abund
determin
base
strength
signal
produc
oligonucleotid
featur
note
provid
mean
survey
transcript
abund
genomewid
scale
sensit
microarray
assay
low
compar
approach
realtim
pcr
microarray
fulli
quantit
assay
chang
transcript
abund
must
measur
refer
control
sampl
need
includ
studi
howev
limit
may
lift
method
reli
highthroughput
sequenc
genomewid
measur
rna
abund
build
legaci
sage
serial
analysi
gene
express
technolog
introduc
rna
sequenc
rnaseq
use
either
total
fraction
rna
exampl
poli
start
point
materi
convert
librari
cdna
fragment
high
throughput
sequenc
fragment
yield
short
sequenc
read
typic
bp
length
depend
technolog
platform
use
given
sampl
ten
million
sequenc
uniqu
map
refer
genom
higher
level
express
given
gene
higher
number
read
align
figur
thu
approach
reli
probe
design
provid
sever
type
inform
includ
transcript
abund
also
transcriptom
structur
splice
variant
profil
noncod
rna
speci
genet
polymorph
rnaseq
expect
becom
suffici
costeffect
practic
eventu
supersed
microarray
technolog
technolog
consid
profil
focus
set
gene
nanostr
technolog
instanc
detect
abund
transcript
high
sensit
approach
digit
sinc
count
individu
rna
molecul
use
string
fluorochrom
report
identifi
differ
rna
speci
technolog
platform
develop
among
other
luminex
high
throughput
genom
fluidigm
round
offer
subgenom
transcript
profil
field
autoimmun
proven
fertil
ground
blood
transcript
studi
alter
transcript
abund
blood
patient
reflect
sustain
respons
selfantigen
gener
uncontrol
inflammatori
process
diseas
often
present
recurringremit
pattern
activ
episod
flare
may
reflect
fluctuat
transcript
abund
work
initi
focus
diseas
clear
system
involv
system
lupu
erythematosu
sle
multipl
cell
type
solubl
mediat
includ
propos
center
lupu
pathogenesi
scatter
evid
indic
potenti
role
type
interferon
lupu
sever
observ
support
hypothesi
first
everi
sle
patient
detect
serum
type
ifn
level
second
dysregul
typei
ifn
product
found
murin
slemodel
third
genet
linkag
associ
studi
identifi
candid
lupu
suscept
gene
within
ifn
pathway
howev
one
earliest
microarray
studi
demonstr
one
pediatr
patient
exhibit
upregul
ifninduc
gene
patient
lack
signatur
remiss
year
addit
found
treat
sle
patient
high
dose
iv
steroid
use
control
diseas
flare
result
silenc
ifn
signatur
surpris
initi
studi
absenc
type
ifn
gene
transcript
face
abund
ifninduc
one
blood
cell
sle
patient
like
explan
cell
produc
type
ifn
therefor
transcrib
gene
migrat
site
injuri
altogeth
result
microarray
studi
play
key
role
convinc
commun
potenti
import
type
ifn
sle
pathogenesi
phase
ia
trial
evalu
safeti
pharmacokinet
immunogen
antiifn
monoclon
antibodi
mab
therapi
adult
sle
patient
recent
conduct
antibodi
elicit
specif
dosedepend
inhibit
overexpress
type
ifninduc
gene
whole
blood
skin
lesion
sle
patient
transcript
protein
level
expect
overexpress
blysbaff
type
ifninduc
gene
also
decreas
treatment
thu
first
trial
support
propos
central
role
type
ifn
human
sle
system
onset
juvenil
arthriti
sojia
anoth
diseas
system
involv
greatli
benefit
studi
blood
transcript
profil
develop
therapeut
diagnost
modal
diseas
specif
organ
involv
also
subject
signific
yet
alway
extens
blood
profil
effort
blood
signatur
instanc
obtain
patient
multipl
sclerosi
given
inaccess
brain
blood
constitut
particularli
attract
sourc
surrog
molecular
marker
diseas
effort
yield
system
signatur
identifi
potenti
predict
marker
clinic
relaps
respons
treatment
transcript
signatur
also
gener
context
dermatolog
diseas
case
target
organ
readili
access
effort
focus
profil
transcript
abund
skin
tissu
howev
system
involv
recogn
recent
year
import
compon
autoimmun
skin
diseas
uniqu
blood
transcript
profil
also
identifi
patient
exampl
psoriasi
blood
transcript
profil
gener
context
mani
autoimmun
diseas
inde
rang
autoimmuneautoinflammatori
diseas
investig
encompass
sle
juvenil
idiopath
arthriti
multipl
sclerosi
rheumatoid
arthriti
sjogren
syndrom
diabet
inflammatori
bowel
diseas
psoriasi
psoriat
arthriti
inflammatori
myopathi
scleroderma
vascul
antiphospholipid
syndrom
bodi
work
produc
focus
blood
transcript
profil
context
autoimmun
diseas
cover
length
recent
review
global
chang
transcript
abund
also
measur
blood
patient
infecti
diseas
context
alter
blood
transcript
profil
reflect
immunolog
respons
mount
host
pathogen
respons
initi
special
receptor
express
surfac
host
cell
recogn
pathogenassoci
molecular
pattern
differ
class
pathogen
signal
differ
combin
receptor
elicit
turn
differ
type
immun
respons
translat
experiment
distinct
transcript
program
induc
upon
exposur
immun
cell
vitro
distinct
class
infecti
agent
similarli
pattern
transcript
abund
measur
blood
patient
infect
caus
differ
etiolog
agent
found
distinct
predict
dramat
chang
observ
blood
patient
system
infect
exampl
sepsi
howev
profound
alter
pattern
transcript
abund
also
found
patient
local
infect
exampl
upper
respiratori
tract
infect
urinari
tract
infect
pulmonari
tuberculosi
skin
abscess
measur
chang
host
transcript
profil
may
therefor
prove
diagnost
valu
even
situat
caus
pathogen
agent
present
test
sampl
importantli
may
also
help
ascertain
sever
infect
monitor
cours
infect
often
present
acut
clinic
event
thu
import
captur
dynam
chang
transcript
abund
occur
cours
infect
time
initi
exposur
blood
signatur
describ
context
acut
infect
caus
wide
rang
pathogen
parasit
virus
bacteria
includ
plasmodium
respiratori
virus
influenza
rhinoviru
respiratori
syncyti
viru
dengu
viru
adenoviru
well
salmonella
mycobacterium
tuberculosi
staphylococcu
aureu
burkholderia
pseudomallei
gener
context
bacteri
sepsi
pathogen
persist
establish
chronic
infect
exampl
human
immunodefici
viru
plasmodium
may
lead
state
latenc
exampl
tuberculosi
transcript
profil
may
use
situat
surveil
tool
monitor
diseas
progress
reactiv
blood
profil
infecti
diseas
remain
limit
scale
particular
addit
studi
necessari
ascertain
dynam
chang
occur
time
addit
autoimmun
infecti
diseas
blood
transcript
profil
studi
carri
cancer
research
field
hematolog
malign
led
way
review
blood
profil
also
obtain
recent
patient
solid
organ
tumor
notabl
signatur
reflect
immunolog
physiolog
chang
effect
cancer
also
presenc
rare
tumor
cell
circul
blood
signatur
also
obtain
solid
organ
transplant
recipi
context
toler
graft
reject
signatur
also
detect
biopsi
materi
blood
offer
distinct
advantag
access
safe
monitor
molecular
chang
routin
basi
work
also
done
context
cardiovascular
diseas
inflamm
known
play
import
role
henc
profil
identifi
wide
rang
condit
includ
stroke
chronic
heart
failur
acut
coronari
syndrom
bodi
publish
work
larg
cite
review
like
tip
iceberg
lot
unpublish
data
scatter
throughout
public
privat
repositori
effort
yield
instanc
blood
transcript
signatur
patient
neurodegen
diseas
associ
diseas
exacerb
respons
glucocorticoid
patient
asthma
respons
environment
exposur
exercis
even
laughter
unfortun
mani
publish
studi
underpow
sometim
lack
even
rudimentari
valid
step
often
primari
data
avail
reanalysi
either
reflect
lack
enforc
editori
polici
absenc
thereof
journal
henc
one
main
challeng
field
move
beyond
proof
principl
stage
consolid
wealth
data
gener
collect
studi
publish
thu
far
demonstr
alter
transcript
abund
detect
genomewid
scale
blood
patient
wide
rang
diseas
statement
far
trivial
given
skeptic
initi
met
studi
investig
blood
transcriptom
patient
also
learn
multipl
diseas
share
compon
blood
transcript
profil
instanc
case
inflamm
interferon
signatur
singl
element
profil
may
specif
given
diseas
combin
element
make
signatur
uniqu
final
work
accomplish
date
highlight
import
carri
analys
aim
directli
compar
transcript
profil
across
diseas
inde
much
learn
instanc
autoimmun
studi
respons
infect
vice
versa
furthermor
effort
may
eventu
lead
us
closer
molecular
classif
diseas
first
howev
technolog
methodolog
advanc
necessari
blood
transcriptom
research
field
move
beyond
proof
principl
stage
year
scale
blood
transcript
studi
constrain
cost
technolog
price
tag
commerci
whole
genom
microarray
us
mark
case
anymor
thu
data
manag
becom
first
essenti
step
make
larg
scale
molecular
profil
viabl
proposit
beyond
store
output
microarray
instrument
data
manag
must
captur
organ
inform
essenti
interpret
result
figur
includ
sampl
inform
data
qualiti
metric
clinic
inform
collect
time
sampl
detail
experiment
design
materi
method
captur
inform
ensur
larg
volum
data
gener
often
publish
immedi
remain
exploit
year
come
point
becom
critic
given
fact
result
genomewid
profil
studi
never
exploit
fullest
extent
possess
consider
cumul
valu
reanalyz
collect
notabl
result
gener
cellular
molecular
profil
platform
also
need
integr
order
complet
pictur
therefor
implement
effect
data
manag
solut
practic
essenti
sustain
necessari
increas
scale
blood
transcript
studi
figur
unfortun
implement
data
manag
solut
laboratori
often
expens
proposit
requir
custom
offtheshelf
product
develop
custom
softwar
adapt
handl
specif
workflow
manag
data
also
take
time
requir
dedic
personnel
thu
need
wide
perceiv
commit
step
necessari
implement
effect
data
manag
solut
practic
rare
adopt
myriad
approach
develop
analysi
genomewid
transcript
profil
data
howev
silver
bullet
come
microarray
data
analysi
challeng
encount
sever
fold
dimension
cope
fact
number
paramet
measur
exce
sever
order
magnitud
number
condit
includ
experi
nois
direct
consequ
first
point
result
microarray
analys
particularli
permiss
nois
fals
discoveri
see
data
data
visual
critic
help
promot
insight
support
data
interpret
biolog
context
import
keep
biolog
sight
time
inde
easi
becom
absorb
data
essenti
use
biolog
knowledg
design
analysi
strategi
final
hardli
onesizefitsal
approach
microarray
data
analysi
work
one
situat
may
univers
applic
inde
common
respons
expert
question
best
way
analyz
given
dataset
depend
depend
instanc
extent
differ
observ
variabl
inher
given
diseas
studi
popul
depend
question
ask
depend
whether
followup
confirmatori
experi
plan
tabl
provid
data
mine
primer
explain
basic
step
involv
microarray
data
analysi
consider
aris
ad
hoc
data
mine
approach
develop
meet
specif
need
instanc
develop
data
mine
strategi
specif
purpos
analyz
blood
transcript
profil
approach
simpli
consist
priori
group
set
gene
similar
transcript
pattern
repeat
sever
differ
dataset
subsequ
compar
cluster
membership
gene
across
dataset
gene
similar
membership
group
togeth
form
term
transcript
modul
structur
data
permit
focus
downstream
statist
test
set
transcript
form
coher
transcript
function
modular
unit
contrast
tradit
approach
reli
iter
statist
test
thousand
individu
transcript
treat
independ
variabl
modular
transcript
framework
develop
reduc
number
variabl
collaps
set
coordin
express
gene
new
entiti
modul
reduc
data
dimension
facilit
function
interpret
enabl
compar
analys
across
multipl
dataset
diseas
minim
nois
improv
robust
biomark
signatur
yield
multivari
metric
use
bedsid
data
visual
also
critic
import
interpret
largescal
dataset
devis
straightforward
visual
scheme
map
global
transcript
chang
individu
diseas
modular
basi
figur
briefli
differ
express
level
studi
group
display
modul
grid
posit
grid
assign
given
modul
red
spot
indic
increas
blue
spot
decreas
transcript
abund
spot
intens
determin
proport
transcript
reach
signific
given
modul
posteriori
biolog
interpret
link
sever
modul
immun
cell
pathway
see
legend
figur
henc
exampl
provid
figur
patient
aureu
infect
demonstr
signific
overexpress
gene
modul
relat
innat
immun
includ
myeloid
neutrophil
inflamm
modul
underexpress
gene
regul
adapt
immun
b
cell
cytotox
cell
tcellspecif
modul
also
note
chang
observ
modul
modul
includ
interferoninduc
gene
abund
would
increas
context
viral
infect
microrna
mirna
control
emerg
critic
regulatori
circuit
immun
system
measur
chang
mirna
abund
blood
human
subject
health
diseas
therefor
promis
new
field
investig
short
noncod
singlestrand
rna
nucleotid
length
found
play
essenti
regulatori
role
molecul
exhibit
highli
specif
regul
pattern
express
control
protein
express
translat
repress
mrna
cleavag
promot
mrna
decay
interestingli
thank
small
size
mirna
molecul
stabl
measur
blood
cell
also
circul
serum
thu
potenti
import
contributor
immun
function
also
potenti
sourc
biomark
blood
transcriptom
research
also
benefit
conceptu
advanc
may
help
address
shortcom
inher
whole
blood
profil
first
blood
complex
tissu
chang
transcript
abund
attribut
either
transcript
regul
rel
chang
composit
leukocyt
popul
two
approach
exist
deconvolut
two
phenomena
first
one
isol
individu
profil
differ
cell
popul
present
blood
approach
may
also
permit
identif
transcript
express
low
level
detect
differ
express
would
otherwis
drown
whole
blood
howev
isol
method
may
introduc
technic
bia
requir
extens
sampl
process
second
approach
consist
deconvolut
whole
blood
transcript
profil
silico
type
analysi
attempt
deduc
cellular
composit
cellspecif
level
gene
express
use
statist
methodolog
final
must
also
keep
mind
immun
statu
human
subject
entir
reflect
blood
profil
obtain
steadi
state
inde
individu
capac
respond
innat
well
antigenspecif
immun
signal
may
also
provid
use
complementari
inform
conclus
blood
transcript
profil
earn
place
molecular
cellular
profil
armamentarium
use
studi
human
immun
system
chang
transcript
abund
recapitul
influenc
genet
epigenet
cellular
environment
factor
initi
consid
belong
cut
edg
approach
becom
robust
practic
discuss
review
becom
mainstay
studi
immun
function
patient
wide
rang
diseas
furthermor
recent
studi
demonstr
util
blood
transcriptom
profil
monitor
immun
respons
drug
vaccin
thu
blood
transcript
profil
develop
mainstream
tool
assess
statu
human
immun
system
